agilon health Statistics
Total Valuation
agilon health has a market cap or net worth of $1.61 billion. The enterprise value is $1.25 billion.
Important Dates
The next confirmed earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
agilon health has 413.00 million shares outstanding. The number of shares has increased by 0.50% in one year.
| Current Share Class | 413.00M |
| Shares Outstanding | 413.00M |
| Shares Change (YoY) | +0.50% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 1.58% |
| Owned by Institutions (%) | 71.52% |
| Float | 305.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| Forward PS | 0.27 |
| PB Ratio | 3.41 |
| P/TBV Ratio | 4.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.09.
| Current Ratio | 1.27 |
| Quick Ratio | 1.24 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -45.97 |
Financial Efficiency
Return on equity (ROE) is -44.22% and return on invested capital (ROIC) is -29.05%.
| Return on Equity (ROE) | -44.22% |
| Return on Assets (ROA) | -10.21% |
| Return on Invested Capital (ROIC) | -29.05% |
| Return on Capital Employed (ROCE) | -48.79% |
| Revenue Per Employee | $5.63M |
| Profits Per Employee | -$241,776 |
| Employee Count | 1,076 |
| Asset Turnover | 3.49 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, agilon health has paid $1.45 million in taxes.
| Income Tax | 1.45M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.11% in the last 52 weeks. The beta is 0.39, so agilon health's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -27.11% |
| 50-Day Moving Average | 4.11 |
| 200-Day Moving Average | 3.71 |
| Relative Strength Index (RSI) | 41.32 |
| Average Volume (20 Days) | 6,663,608 |
Short Selling Information
The latest short interest is 18.27 million, so 4.42% of the outstanding shares have been sold short.
| Short Interest | 18.27M |
| Short Previous Month | 16.82M |
| Short % of Shares Out | 4.42% |
| Short % of Float | 5.97% |
| Short Ratio (days to cover) | 3.20 |
Income Statement
In the last 12 months, agilon health had revenue of $6.06 billion and -$260.15 million in losses. Loss per share was -$0.63.
| Revenue | 6.06B |
| Gross Profit | 4.84M |
| Operating Income | -283.96M |
| Pretax Income | -296.85M |
| Net Income | -260.15M |
| EBITDA | -259.49M |
| EBIT | -283.96M |
| Loss Per Share | -$0.63 |
Full Income StatementBalance Sheet
The company has $399.97 million in cash and $43.96 million in debt, giving a net cash position of $356.01 million or $0.86 per share.
| Cash & Cash Equivalents | 399.97M |
| Total Debt | 43.96M |
| Net Cash | 356.01M |
| Net Cash Per Share | $0.86 |
| Equity (Book Value) | 470.95M |
| Book Value Per Share | 1.14 |
| Working Capital | 305.77M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$57.78 million and capital expenditures -$13.25 million, giving a free cash flow of -$71.03 million.
| Operating Cash Flow | -57.78M |
| Capital Expenditures | -13.25M |
| Free Cash Flow | -71.03M |
| FCF Per Share | -$0.17 |
Full Cash Flow StatementMargins
Gross margin is 0.08%, with operating and profit margins of -4.69% and -4.29%.
| Gross Margin | 0.08% |
| Operating Margin | -4.69% |
| Pretax Margin | -4.11% |
| Profit Margin | -4.29% |
| EBITDA Margin | -4.28% |
| EBIT Margin | -4.69% |
| FCF Margin | n/a |
Dividends & Yields
agilon health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.50% |
| Shareholder Yield | n/a |
| Earnings Yield | -16.15% |
| FCF Yield | -4.41% |
Dividend DetailsAnalyst Forecast
The average price target for agilon health is $4.47, which is 15.06% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.47 |
| Price Target Difference | 15.06% |
| Analyst Consensus | Hold |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 10.85% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
agilon health has an Altman Z-Score of 2.85 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.85 |
| Piotroski F-Score | 2 |